About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Migraine Clinical Trials in Phoenix | 110 Studies

Clinical Trials MigrainePhoenix

Migraine Clinical Trials in Phoenix

Find 110 clinical trials for migraine near Phoenix, Arizona. Connect with research centers in your area.

All Migraine trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 110 trials

CompletedA Study of Galcanezumab (LY2951742) in Participants With Migraine HeadacheThe main purpose of this study is to evaluate whether the study drug known as galcanezumab is safe and effective in the prevention of migraine headaches.NCT02163993·Gilbert, Arizona and 39 others

Migraine Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingA Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in AdultsThe purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing chronic migraine.NCT06047444·Birmingham, Alabama and 119 others

CompletedA Study of LY3451838 in Participants With MigraineThe reason for this study is to see if the study drug LY3451838 is safe and effective in participants who have migraine that have not responded to other preventive treatments.NCT04498910·Phoenix, Arizona and 8 others

CompletedAn Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 MonthsThe primary objective is to evaluate the safety of long-term treatment with NP101 as assessed by: * Subject self-examination skin irritation scores * Adverse events * Changes in…NCT00792103·Phoenix, Arizona and 33 others

CompletedMaximizing Outcomes in Treating Acute MigraineAXS-07 is an oral, investigational medicine consisting of MoSEIC meloxicam and rizatriptan, which is being developed for the acute treatment of migraine with or without aura in…NCT03896009·Birmingham, Alabama and 84 others

Active not recruitingStudy of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual MigraineA migraine is a moderate to severe headache typically on one side of the head.NCT06417775·Birmingham, Alabama and 105 others

CompletedEfficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic MigraineThis study evaluated the efficacy, safety and tolerability of atogepant in participants with chronic migraine. This study included a 12-week treatment period.NCT03855137·Phoenix, Arizona and 149 others

CompletedAcute Treatment Trial in Adult Subjects With MigrainesThe purpose of the study is to evaluate the safety and efficacy of three different intranasal dose levels of zavegepant (BHV-3500), relative to placebo, in the acute treatment of…NCT03872453·Mobile, Alabama and 81 others

CompletedSafety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine PreventionThe purpose of this study is to further evaluate the long-term safety and tolerability of daily dosing of rimegepant for the prevention of episodic migraine.NCT05207865·Phoenix, Arizona and 18 others

CompletedNINDS CRC Chronic Migraine Treatment TrialThe purpose of this study is to compare the reduction in the number of severe headache days at six months in people with chronic migraine treated with topiramate and propranolol…NCT00772031·Phoenix, Arizona and 38 others

CompletedEfficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLETo evaluate the efficacy and safety of zolmitriptan nasal spray (ZNS) in the acute treatment of migraine headache in subjects ages 6 to 11 years.NCT03275922·Phoenix, Arizona and 46 others

RecruitingA Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic MigraineIn this clinical trial, participants with episodic migraine will receive injections with Xeomin or Placebo into muscles of the head and neck.NCT07018700·Chandler, Arizona and 109 others

CompletedA Multicenter Assessment of ALD403 in Chronic MigraineThe purpose of this study is to assess ALD403 in the prevention of migraine headache in chronic migraineurs.NCT02275117·Huntsville, Alabama and 91 others

TerminatedThe Childhood and Adolescent Migraine Prevention StudyThe purpose of this research study is to test two medicines for migraine prevention in children and adolescents.NCT01581281·Phoenix, Arizona and 34 others

Active not recruitingObservational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With MigraineMigraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound.NCT06543914·Hoover, Alabama and 111 others

CompletedA Study of Galcanezumab (LY2951742) in Adult Participants With Episodic MigraineThe purpose of this study is to assess whether galcanezumab is superior to rimegepant in the prevention of migraine in participants with episodic migraine.NCT05127486·Gilbert, Arizona and 76 others

CompletedExtension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic MigraineThe purpose of this study is to evaluate the safety and tolerability of atogepant 60 mg once a day for the prevention of migraine in participants with episodic migraine.NCT03939312·Chandler, Arizona and 112 others

CompletedThe MOTS (Medication Overuse Treatment Strategy) TrialThere are two commonly used treatment strategies for treating patients who have chronic migraine with medication overuse.NCT02764320·Flagstaff, Arizona and 28 others

CompletedStudy to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine PreventionThe primary objective of the study was to evaluate the effect of erenumab compared to placebo on the change from baseline in monthly migraine days.NCT02456740·Phoenix, Arizona and 128 others

CompletedStudy Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine AttacksThe purpose of this study is to determine the consistency of response for Treximet (formerly known as Trexima) when treating four acute migraine attacks at the mild pain phase and…NCT00240617·Anniston, Alabama and 51 others

Page 1 of 6Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia